ArticleColombia medica (Cali, Colombia)2018
Cali cancer registry methods.
Article in Colombia medica (Cali, Colombia), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic review.Pharmacology research & perspectives · 2020Pooled it
- Survival of patients with mucosal melanoma in Cali, Colombia: a retrospective cohort study.BMC cancer · 2024Article
- Deterministic linkage for improving follow-up time in a Brazilian population-based cancer registry.Scientific reports · 2023Article
- Gastric adenocarcinoma burden, trends and survival in Cali, Colombia: A retrospective cohort study.Frontiers in oncology · 2023Article
- Colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study.Revista brasileira de epidemiologia = Brazilian journal of epidemiology · 2023Article
- Head and neck cancer in Cali, Colombia: Population-based study.Community dentistry and oral epidemiology · 2022Article
- A spatial randomness test based on the box-counting dimension.Advances in statistical analysis : AStA : a journal of the German Statistical Society · 2022Article
- Strengthening Pathology Capacity to Deliver Quality Cancer Care in Cities in LMICs.JCO global oncology · 2021Article
- Incidence, Mortality, and Survival Trends of Primary CNS Tumors in Cali, Colombia, From 1962 to 2019.JCO global oncology · 2020Article
- Mortality from respiratory infections and chronic non-communicable diseases before the COVID-19 pandemic in Cali, Colombia.Colombia medica (Cali, Colombia) · 2020Review
- Article
- Reliable information for cancer control in Cali, Colombia.Colombia medica (Cali, Colombia) · 2018Article
- Epidemiology of cancer in Colombia.Colombia medica (Cali, Colombia) · 2018Article
- Incidence and mortality by cancer in the Pasto municipality, Colombia. 2013-2017.Colombia medica (Cali, Colombia)Observational
- Survival in stomach cancer: analysis of a national cancer information system and a population-based cancer registry in Colombia.Colombia medica (Cali, Colombia)Article
- Cancer epidemiology in Cali, 60 years of experience.Colombia medica (Cali, Colombia)Article
- Survival of patients living with HIV and cancer in Cali, Colombia.Colombia medica (Cali, Colombia)Article
- Trends in cancer incidence and mortality in Manizales, Colombia, 2008-2017.Colombia medica (Cali, Colombia)Article
- Trends in long-term cancer survival in Cali, Colombia: 1998-2017.Colombia medica (Cali, Colombia)Article
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
Abstract
backgroundThe Population Cancer Registry of Cali (RPCC) has operated since 1962, disseminating high quality information to provide a framework to assess and control the burden of cancer in Cali.
methodsThe collection of new cancer cases in permanent residents of Cali is done through active search in and notification from hospitals, and public and private laboratories. The Secretary of Municipal Public Health provides individual information on general mortality and death from cancer. Tumors are coded with ICDO-3 and mortality with ICD-10. Presented rates are standardized by age and trends are assessed by estimating the percentage annual change using the regression analysis in JoinPoint. The 5-year net survival was analyzed with the Pohar-Perme estimator.
resultsThe 88.5% of the registered cancers had morphological verification (MV). The proportion of unknown primary site represented 5% and the death certificate only cases (DCO) varied between 0 to3% depending on the cancer site. All deaths were certified by a physician, 94.2% of cancer deaths were correctly certified. The ill-defined site proportion was 5.3% and that of uterine cancer not specified (C55) was 0.5%. For survival analysis, existing data collection procedure and infrastructure ensures assessment of the patient's vital status and follow-up, with an average lost to follow-up of 13.2%. COMMENT: The information has been published in the eleven volumes of "Cancer Incidence in Five Continents" confirming high quality of the collected data. The RPCC PCRC has also participated in the Concord Study and is participating in SURVCAN-3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.